Earth Science Tech Inc. (OTC: ETST) is advancing its market position by leveraging proprietary technology and strategic investments in the telehealth and peptide therapy sectors, according to a recent company announcement. The holding company, which acquires and manages operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and consumer markets, is focusing on vertical integration and innovation to capture shares of rapidly expanding markets.
The telehealth industry, where ETST has established a presence through subsidiaries such as DOConsultations LLC and Las Villas Health Care Inc., is projected to reach $251.5 billion by 2030, reflecting a compound annual growth rate (CAGR) of 11.3% between 2025 and 2030 (https://ibn.fm/EiRW6). This growth is driven by increasing demand for remote healthcare services and technological advancements.
Additionally, the company is capitalizing on the surging demand for peptide therapies, a market expected to hit $249 billion by 2033. Peptide therapies are gaining clinical acceptance for treating various conditions, and ETST's investments in this area are positioned to benefit from the trend.
ETST's competitive edge lies in its proprietary technology and IT infrastructure, which enable efficient operations and scalability. The company continues to push innovative tech development and expand vertical integration, allowing it to identify unique market opportunities and steadily grow its market share.
By integrating its subsidiaries and leveraging synergies across pharmaceuticals, telemedicine, and healthcare services, ETST aims to create a comprehensive ecosystem that can adapt to evolving industry demands. The company's strategic positioning in high-growth sectors underscores its potential to deliver value to stakeholders as these markets mature.
For more information on ETST, visit the company's newsroom at https://ibn.fm/ETST.
